Appili Therapeutics Inc (APLI)

Currency in CAD
0.0200
0.0000(0.00%)
Closed·
APLI Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected tomorrow
APLI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.02000.0200
52 wk Range
0.01000.0450
Key Statistics
Bid/Ask
0.015 / 0.02
Prev. Close
0.02
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.01-0.045
Volume
111
Average Volume (3m)
85.94K
1-Year Change
-50%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APLI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Appili Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Appili Therapeutics Inc Company Profile

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

Compare APLI to Peers and Sector

Metrics to compare
APLI
Peers
Sector
Relationship
P/E Ratio
−0.9x−0.1x−0.5x
PEG Ratio
−0.030.000.00
Price/Book
−0.2x0.9x2.6x
Price / LTM Sales
24.1x0.7x3.3x
Upside (Analyst Target)
-33.1%43.4%
Fair Value Upside
Unlock23.1%7.1%Unlock

Earnings

Latest Release
Jun 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-12,610.00 / --
EPS Revisions
Last 90 days

APLI Income Statement

FAQ

What Stock Exchange Does Appili Therapeutics Trade On?

Appili Therapeutics is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Appili Therapeutics?

The stock symbol for Appili Therapeutics is "APLI."

What Is the Appili Therapeutics Market Cap?

As of today, Appili Therapeutics market cap is 2.43M.

What Is Appili Therapeutics's Earnings Per Share (TTM)?

The Appili Therapeutics EPS (TTM) is -0.02.

When Is the Next Appili Therapeutics Earnings Date?

Appili Therapeutics will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is APLI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Appili Therapeutics Stock Split?

Appili Therapeutics has split 0 times.

How Many Employees Does Appili Therapeutics Have?

Appili Therapeutics has 7 employees.

What is the current trading status of Appili Therapeutics (APLI)?

As of 10 Aug 2025, Appili Therapeutics (APLI) is trading at a price of 0.02, with a previous close of 0.02. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.01 to 0.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.